| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|---|---|---|---|---|---|---|---|
Product sales | ||||||||
- | - | - | - | 1 | - | - | - | - |
Diagnostic testing service | ||||||||
- | - | - | - | - | 40 | 409 | 475 | 0 |
Product sales | ||||||||
- | - | - | - | - | 0 | 223 | 6 | 1 |
Net revenue | ||||||||
- | - | - | - | 1 | 40 | 632 | 481 | 1 |
Diagnostic testing services | ||||||||
- | - | - | - | - | - | 105 | 35 | 0 |
Product sales | ||||||||
- | - | - | - | 132 | 0 | 239 | 0 | 5 |
Cost of revenue | ||||||||
- | - | - | - | 132 | 0 | 345 | 35 | 5 |
Loss on obsolete inventory | ||||||||
- | - | - | - | - | - | 149 | 29 | - |
Loss on Reduction of Inventory to LCM | ||||||||
- | - | - | - | - | - | - | - | 92 |
Gross profit | ||||||||
- | - | - | - | -130 | 40 | 137 | 416 | -95 |
Operating expenses | ||||||||
Selling expenses | ||||||||
- | - | - | - | 1,421 | 695 | 1,257 | 466 | 160 |
Research and development | ||||||||
6,645 | 4,209 | 2,328 | 770 | 2,359 | 1,110 | 1,105 | 1,974 | - |
General and administrative | ||||||||
10,620 | 7,224 | 4,859 | 6,479 | 8,846 | 8,052 | 8,558 | 3,044 | 3,172 |
Impairment of intangible assets | ||||||||
- | - | 461 | 718 | 0 | 2,352 | 0 | - | - |
Total operating expenses | ||||||||
17,265 | 11,434 | 7,649 | 7,968 | 12,627 | 12,211 | 10,921 | 5,485 | 3,333 |
Operating loss | ||||||||
-17,265 | -11,434 | -7,649 | -7,968 | -12,758 | -12,171 | -10,784 | -5,069 | -3,429 |
Change in fair value of common stock warrants | ||||||||
- | - | 280 | - | - | - | - | - | - |
Warrant financing expense | ||||||||
- | - | 192 | - | - | - | - | - | - |
Other income (expense) | ||||||||
- | - | - | 1,599 | 0 | 0 | - | - | - |
Other expense | ||||||||
25 | 29 | 0 | - | - | - | - | - | - |
Interest income | ||||||||
- | - | - | - | - | - | 0 | 1 | 4 |
Interest expense | ||||||||
- | - | - | - | - | - | 0 | 12 | 17 |
Loss before income taxes | ||||||||
- | - | - | -6,368 | - | -12,170 | -10,784 | -5,079 | -3,442 |
Loss before income taxes | ||||||||
-17,239 | -11,404 | -8,122 | - | -12,758 | - | - | - | - |
Income taxes | ||||||||
0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
Loss from operations | ||||||||
- | - | - | - | -12,758 | -12,170 | - | - | - |
Loss from discontinued operations | ||||||||
- | - | - | - | -3,002 | -2,487 | - | - | - |
Net loss | ||||||||
-17,239 | -11,404 | -8,122 | -6,368 | -15,760 | -14,657 | -10,784 | -5,079 | -3,442 |
Deemed dividend attributable to preferred stock | ||||||||
- | 11,479 | 2,568 | - | - | - | - | - | - |
Net loss applicable to common shareholders | ||||||||
-17,239 | -22,884 | -10,690 | -6,368 | - | - | - | - | - |
Loss per common share from continuing operations - basic and diluted (in dollars per share) | ||||||||
- | - | - | - | -6.73 | -0.51 | - | - | - |
Loss per common share from discontinued operations- basic and diluted (in dollars per share) | ||||||||
- | - | - | - | -1.58 | -0.10 | - | - | - |
Loss per common share - basic and diluted (in dollars per share) | ||||||||
-2.03 | -5.50 | -10.97 | -2.16 | -8.31 | -0.61 | -0.70 | -0.41 | -0.38 |
Weighted average shares outstanding - basic and diluted (in shares) | ||||||||
8,496 | 4,157 | 974 | 2,947 | 1,895 | 24,038 | 15,484 | 12,452 | 9,117 |